Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

被引：0
|
作者：
María-Isabel Farfan-Portet
Sophie Gerkens
Isabelle Lepage-Nefkens
Irmgard Vinck
Frank Hulstaert
机构：
[1] Belgian Health Care Knowledge Centre,
来源：
The European Journal of Health Economics | 2014年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：223 / 228
页数：5
相关论文
共 50 条
  • [1] Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
    Farfan-Portet, Maria-Isabel
    Gerkens, Sophie
    Lepage-Nefkens, Isabelle
    Vinck, Irmgard
    Hulstaert, Frank
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (03): : 223 - 228
  • [2] IMPACT OF COST-CONTAINMENT POLICIES ON BIOSIMILARS MARKET
    Putignano, D.
    Fiorentino, D.
    Guerriero, F.
    Monetti, V. M.
    Orlando, V
    Menditto, E.
    VALUE IN HEALTH, 2014, 17 (07) : A415 - A415
  • [3] Cost-Containment as Part of Pharmaceutical Policy
    Anna Birna Almarsdóttir
    Janine M. Traulsen
    Pharmacy World and Science, 2005, 27 : 144 - 148
  • [4] Cost-containment as part of pharmaceutical policy
    Almarsdóttir, AB
    Traulsen, JM
    PHARMACY WORLD & SCIENCE, 2005, 27 (03): : 144 - 148
  • [5] Pharmaceutical cost-containment policy: experiences in Shanghai, China
    Hu, SL
    Chen, W
    Cheng, XM
    Chen, KY
    Zhou, HY
    Wang, LX
    HEALTH POLICY AND PLANNING, 2001, 16 : 4 - +
  • [6] TARGET DRUG PROGRAMS - A COST-CONTAINMENT TOOL
    NEU, HC
    HOSPITAL FORMULARY, 1987, 22 (05): : 413 - 413
  • [7] COST-CONTAINMENT
    FROHLICH, EP
    SOUTH AFRICAN MEDICAL JOURNAL, 1994, 84 (03): : 168 - 168
  • [8] HOW DO COST-CONTAINMENT MEASURES IMPACT PHARMACEUTICAL INDUSTRY?
    Zimmermann, N.
    Gombocz, M.
    Vogler, S.
    VALUE IN HEALTH, 2016, 19 (07) : A498 - A498
  • [9] Pharmaceutical Cost-Containment Policies and Sustainability: Recent Irish Experience
    Kenneally, Martin
    Walshe, Valerie
    VALUE IN HEALTH, 2012, 15 (02) : 389 - 393
  • [10] ANTIBIOTIC COST-CONTAINMENT
    HUCKLEBERRY, SD
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (7-8): : 589 - 591
12345